Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Andreone

Showing results (161-170 of 189) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|June 22, 2023
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis DHeiner Wedemeyer, Soo Aleman, Maurizia Rossana Brunetto, et al.
Journal of Hepatology|April 12, 2026
144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and posttreatment results from a Phase 3 randomized trialHeiner Wedemeyer, Soo Aleman, Antje Blank, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for retreatment of HCV infectionStefan Zeuzem, Pietro Andreone, Stanislas Pol, et al.
Minerva Gastroenterologica E Dietologica|January 9, 2018
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohortAlfredo Marzano, Pietro Andreone, Patrizia Boccagni, et al.
Journal of Hepatology|May 11, 2024
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trialHeiner Wedemeyer, Soo Aleman, Maurizia Brunetto, et al.
Annals of Hepatology|February 13, 2022
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up studyStefano Gitto, Paolo Magistri, Luca Marzi, et al.
Gut|July 20, 2024
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis BAndrea Vecchi, Marzia Rossi, Camilla Tiezzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 11, 2017
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network studyAntonio Massimo Ippolito, Michele Milella, Vincenzo Messina, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 12, 2020
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational studyAlessio Aghemo, Alfredo Alberti, Pietro Andreone, et al.
Free Radical Biology & Medicine|February 21, 2012
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trialCarmela Loguercio, Pietro Andreone, Ciprian Brisc, et al.
Pageof 19

Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|June 22, 2023
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis DHeiner Wedemeyer, Soo Aleman, Maurizia Rossana Brunetto, et al.
Journal of Hepatology|April 12, 2026
144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and posttreatment results from a Phase 3 randomized trialHeiner Wedemeyer, Soo Aleman, Antje Blank, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for retreatment of HCV infectionStefan Zeuzem, Pietro Andreone, Stanislas Pol, et al.
Minerva Gastroenterologica E Dietologica|January 9, 2018
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohortAlfredo Marzano, Pietro Andreone, Patrizia Boccagni, et al.
Journal of Hepatology|May 11, 2024
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trialHeiner Wedemeyer, Soo Aleman, Maurizia Brunetto, et al.
Annals of Hepatology|February 13, 2022
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up studyStefano Gitto, Paolo Magistri, Luca Marzi, et al.
Gut|July 20, 2024
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis BAndrea Vecchi, Marzia Rossi, Camilla Tiezzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 11, 2017
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network studyAntonio Massimo Ippolito, Michele Milella, Vincenzo Messina, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 12, 2020
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational studyAlessio Aghemo, Alfredo Alberti, Pietro Andreone, et al.
Free Radical Biology & Medicine|February 21, 2012
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trialCarmela Loguercio, Pietro Andreone, Ciprian Brisc, et al.
Pageof 19